American Oncology Network Announces Dave Gould Will Step Down As Chief Financial Officer, Effective May 17, 2024; AON Has Initiated A Process For A New CFO
Portfolio Pulse from Benzinga Newsdesk
American Oncology Network (AON) announced CFO Dave Gould will step down on May 17, 2024. David Afshar is appointed as interim CFO starting May 20, 2024. AON is initiating a search for a new CFO. Afshar brings over 25 years of experience in healthcare services, including roles in companies with revenues ranging from $300 million to over $1.8 billion. CEO Todd Schonherz thanked Gould for his contributions, especially in helping AON become a public company, and expressed confidence in the company's strategic plans and growth opportunities.
May 03, 2024 | 10:37 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
AONC's CFO Dave Gould will step down in May 2024, succeeded by David Afshar as interim CFO. The company is searching for a new CFO. Afshar's extensive experience in healthcare finance is expected to support AON's growth and strategic plans.
The announcement of a CFO stepping down and the appointment of an interim CFO with significant experience in the sector may have a neutral to slightly positive impact on AONC's stock price in the short term. While executive transitions can introduce uncertainty, the appointment of a seasoned executive like Afshar, with a strong background in healthcare finance, may mitigate concerns and potentially reassure investors about the company's financial leadership and strategic direction.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90